{
    "organizations": [],
    "uuid": "dc635614023cc33e334ba5f4ec4ebeaaa873d971",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-precision-therapeutics-forms-tumor/brief-precision-therapeutics-forms-tumorgenesis-subsidiary-idUSFWN1QH11P",
    "ord_in_thread": 0,
    "title": "BRIEF-Precision Therapeutics Forms Tumorgenesis Subsidiary",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 27 (Reuters) - Precision Therapeutics Inc:\n* PRECISION THERAPEUTICS FORMS TUMORGENESIS INC. SUBSIDIARY TO FOCUS ON THE NEXT GENERATION OF PATIENT DERIVED TUMOR MODELS\n* ‍FORMED TUMORGENESIS TO DEVELOP A NEW, RAPID APPROACH TO GROWING TUMORS IN LABORATORY​\n* ‍TESTING OF TUMORGENESIS PDX TUMORS TO TAKE PLACE IN COLLABORATION WITH HELOMICS, IN WHICH CO HAS 20% EQUITY STAKE​\n* IN NEGOTIATIONS WITH MEDICAL TECHNOLOGY COS TO LICENSE THEIR TECHNOLOGY TO ADVANCE TUMORGENESIS‘S STRATEGIC PLAN​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-27T21:44:00.000+02:00",
    "crawled": "2018-02-28T12:56:15.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "precision",
        "therapeutic",
        "inc",
        "precision",
        "therapeutic",
        "form",
        "tumorgenesis",
        "subsidiary",
        "focus",
        "next",
        "generation",
        "patient",
        "derived",
        "tumor",
        "model",
        "tumorgenesis",
        "develop",
        "new",
        "rapid",
        "approach",
        "growing",
        "tumor",
        "tumorgenesis",
        "pdx",
        "tumor",
        "take",
        "place",
        "collaboration",
        "helomics",
        "co",
        "equity",
        "negotiation",
        "medical",
        "technology",
        "co",
        "license",
        "technology",
        "advance",
        "tumorgenesis",
        "strategic",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}